HAVCR2 and glioma: Finally, one study has assessed TIM-3 expression on natural killer T (NKT) cells in the glioma setting and found no significant difference in the percentage of TIM-3 positivity on NKT cells from glioma patients compared to NKT cells from healthy individuals [70].